By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Tonix Pharmaceuticals, Inc. 

509 Madison Ave.
Suite 306
New York  New York  10022  U.S.A.
Phone: 212-980-9155 Fax: 212-923-5700




Company News
Tonix Pharma (TNXP) Announces Full Exercise And Closing Of Underwriters’ Over-Allotment Option 7/13/2016 8:34:38 AM
Tonix Pharma (TNXP) To Present At Cantor Fitzgerald’s 2nd Annual Healthcare Conference 7/8/2016 9:50:30 AM
Tonix Pharma (TNXP) Presents Pharmacokinetic Data On TNX-102 SL As A Potential Treatment For The Management Of Fibromyalgia And Treatment Of Post-Traumatic Stress Disorder At The ASCPT 2016 Annual Meeting 3/9/2016 8:00:11 AM
Tonix Pharma (TNXP) CEO Toured Midtown To Raise Cash 3/2/2016 8:11:40 AM
Tonix Pharma (TNXP) Appoints Chief Financial Officer 2/26/2016 7:56:58 AM
Tonix Pharma (TNXP) Craters as Headache Drug Flunks Phase II Study 2/16/2016 9:43:33 AM
TONIX Pharmaceuticals, Inc. (TNXP) Completes Enrollment In Phase 2 Clinical Trial Of TNX-102 SL In Post-Traumatic Stress Disorder (PTSD) 12/23/2015 10:22:20 AM
TONIX Pharmaceuticals, Inc. (TNXP) Completes Enrollment In Phase II Clinical Study Of TNX-201 In Episodic Tension-Type Headache 12/8/2015 9:24:54 AM
TONIX Pharmaceuticals, Inc. (TNXP) And U.S. Department Of Defense Military Developer In Partnership To Expand Efforts To Examine TNX-102 SL For Post-Traumatic Stress Disorder 12/7/2015 8:07:37 AM
TONIX Pharmaceuticals, Inc. (TNXP) To Participate In Fireside Chat At The Oppenheimer 26th Annual Healthcare Conference 12/1/2015 8:07:57 AM